chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I normally get psoriasis outbreak. The last time was in April. The outbreak was different. It was much more severe and located in different areas. I normally get the outbreak on my fingertips. This time it was on the scalp, face, back and palm and top of hand. I went to my doctor who did bloodwork and referred me to a rheumatologist who prescribed multiple different types of ointment. I was prescribed clobetasol propionate topical solution, desonide cream 0.05, triamcinolone acetonide ointment and allowed to go home. This issue is still ongoing. I am still seeking care from the rheumatologist and primary care doctor. I am receiving IV infusions currently from the specialist.
Patient states she had severe anxiety prior to Covid vaccine today and prior to today. Husband checked her BS at home and glucose monitor read 92. Vitals taken: 02 97%, HR 85. At 1012 patient states she feels back to normal and appears well. Patient given water and a snack.
A spontaneous report (United States) was received from an employee and a physician concerning a patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered with product that was exposed to room temperature for more than twelve hours.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 04 Jan 2021, a freezer containing a vial of mRNA-1273 failed.  At 1:11 A.M. the vial experienced a temperature excursion, exceeding 8 degrees Celsius. Over time the dose thawed and reached room temperature.  On 04 Jan 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection and was administered with product that was exposed to room temperature for more than twelve hours.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The event, administered with product that was exposed to room  temperature for more than twelve hours, was resolved on 04 Jan 2021.; Reporter's Comments: This case concerns a patient of unknown gender and age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product that was exposed to room temperature for more than twelve hours without any associated adverse events.
For 1-3 days after injection, occasional chills/sweats noted and some joint pain, sensitivity to sound/light, severe headache; for 3-5 days after injection, significant pain radiating around to neck/shoulders that was able to be largely controlled with ibuprofen; for just over a week after injection, some shortness of breath and abnormal fatigue noted, particularly late in day; since injection, some tightness/mild pressure in chest and discomfort in left arm continues intermittently and is most noticeable when lying down (no actual pain in chest) but can be eased with ibuprofen  Did not seek medical help given mild nature of symptoms but took ibuprofen given similarities to symptoms associated with pericarditis or myocarditis. Symptoms for both this vaccination and prior instance after second vaccine (Pfizer) occurred shortly after vigorous physical activity
Blister really hot; scratchy throat; really hot; Congestion; Back rash; Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion) and RASH (Back rash) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion), RASH (Back rash) and VACCINATION SITE RASH (Vaccination site rash). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion), RASH (Back rash) and VACCINATION SITE RASH (Vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator
This spontaneous report as received from a female consumer of unknown age refers to herself. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose and route unspecified). After receiving the shot, in 2014, between 29-JUL-2014 to 01-AUG-2014 the patient developed an allergic reaction. The reaction caused an infection and the patient went to the doctor. The patient stated that they were put on an antibiotic. The events outcome was unknown. Additional information has been requested.
pain Narrative: employee states: "waking up the next morning my body felt like a truck hit me and I could not move I was in so much pain. States took 800mg Motrin and slept. stayed home from work. was not able to fully move until approximately 12 that day"
Within 20 minutes of getting my second dose shot my head felt very cloudy and weird.  By 9:30pm that evening I was extremely tired and starting to ache.  I had a hard time sleeping and getting comfortable that night and woke up the next morning with a terrible headache and a very very sore arm.  By noon I felt like I was not able to function.  I had severe chills (it felt like someone had drilled a hole in my head and was pouring ice water into it that would then run the length of my body).  My head hurt and every joint in my body ached.  I alternated between sleeping and crying.  Around 10:30pm my chills finally broke and the sweats started and continued through the next morning.  By noon on 4/15 I was feeling back to normal.
Stroke; throwing up all night; Gut problem; A spontaneous report was received from a consumer  concerning a 75-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced gut problem,stroke and throwing up all night.   The patient's medical history, as provided by the reporter, included stroke.Concomitant medications was not provided by the reporter.  On 03 Mar 2021 prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Batch number: unknown)  for prophylaxis of COVID-19 infection.   After receiving mRNA-1273, on 14 Mar 2021, the patient was hospitalized for "gut problems" and throwing up all night, and was treated with antibiotics.  On 17 Mar 2021 patient experienced the event stroke .Lab tests done included brain scan ,no bleeding found.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events gut problem,stroke and throwing up all night was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt was in for immunizations today.  After receiving immunizations pt had syncopal episode and fell, striking his head on the floor.  Witnessed by two MAs. Vital signs assessed and ice pack placed on left forehead for redness and swelling.  Pt awake after 30 seconds and c/o headache. Moved to chair after 10 minutes. Examined by Dr. Assisted to car with mom, scheduled for follow up visit tomorrow with Dr.
arm is slightly tender; shivering uncontrollably; temperature of 104 degrees, then 101 degrees, then 99.8 degrees, then 100 degrees Fahrenheit; felt the vaccine going into her arm; arm was sore when raised above head; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt the vaccine going into her arm), PAIN IN EXTREMITY (arm was sore when raised above head), CHILLS (shivering uncontrollably), PYREXIA (temperature of 104 degrees, then 101 degrees, then 99.8 degrees, then 100 degrees Fahrenheit) and TENDERNESS (arm is slightly tender) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FEELING ABNORMAL (felt the vaccine going into her arm) and PAIN IN EXTREMITY (arm was sore when raised above head). On 27-Feb-2021, the patient experienced CHILLS (shivering uncontrollably) and PYREXIA (temperature of 104 degrees, then 101 degrees, then 99.8 degrees, then 100 degrees Fahrenheit). On 02-Mar-2021, the patient experienced TENDERNESS (arm is slightly tender). At the time of the report, FEELING ABNORMAL (felt the vaccine going into her arm), PAIN IN EXTREMITY (arm was sore when raised above head), CHILLS (shivering uncontrollably), PYREXIA (temperature of 104 degrees, then 101 degrees, then 99.8 degrees, then 100 degrees Fahrenheit) and TENDERNESS (arm is slightly tender) outcome was unknown.
Lack of drug effect; Lack of drug effect; Ache; Fatigue; This is a solicited report received from a contactable consumer (patient), other healthcare professional and based on the information received by Pfizer (MFR Control No. #Mfr. Control No.: 21K-163-3887269-00). This is a Non-interventional clinical study case reporting non-serious events only.  A 31-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) via intramuscular route on 29Apr2021, (at the age of 31-year-old) as single dose for COVID-19 immunization; adalimumab (HUMIRA), subcutaneous from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at CF for ankylosing spondylitis. The patient's medical history and concomitant medications were not reported.  On 30Apr2021 the patient experienced ache and fatigue, moreover it was reported that on an unknown date the patient also experienced "Lack of drug effect" (it was unclear if referred to HUMIRA or to BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine) on an unspecified date. At the time of the report the events ache and fatigue were recovering, whereas other events were not recovered.  The reporter considered that there was not a reasonable possibility that the reported events were related to adalimumab and BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Follow-up (02Jun2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.  Follow-up (09Jul2021): This follow-up report is being submitted to amend previously reported Information: event covid-19 was added and assessed as serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: The patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine on 29Apr2021; adalimumab (HUMIRA) from an unspecified date to an unspecified date for ankylosing spondylitis.  On 30Apr2021, the patient experienced ache and fatigue, and on an unknown date the patient experienced  "Lack of drug effect".  On 06May2021, the reporter reported that there was not a reasonable possibility that the reported events were related to adalimumab and COVID-19 mRNA Vaccine.  Considering temporal relationship, a possible contribution role of COVID-19 mRNA Vaccine to the onset of ache and fatigue cannot be excluded. Considering the very short time lag, the case does not meet the criteria of vaccine Lack of drug effect. This case will be reassessed should additional information become available.
temperature reached 100.02; muscle pain; not totally feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "he got the virus", start date: Jul2020 (not ongoing), notes: The caller stated that he got the virus last July 2020 and recovered from it. The patient's concomitant medications were not reported. The following information was reported: BODY TEMPERATURE INCREASED (non-serious), outcome "unknown", described as "temperature reached 100.02"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain"; MALAISE (non-serious), outcome "unknown", described as "not totally feeling well". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: after he got the 1st dose of the vaccine, he stated that his temperature reached 100.02, and he had muscle pain and he is not totally feeling well. He wants to know what he can do to get better.  No follow-up attempts are possible. No further information is expected.
Within a few hours I did not feel well and started to shiver. I had to go to bed early and the next day I was feeling so fatigued that I could not get out of bed. I stayed in bed all day. I had to cancel a flight for the next day because I didnt know how long I would feel sick. I shivered all day.
the next day p/vax lt arm very swollen, red, warm, from elbow to upper arm;small cluster of water blisters also @ site;
At 2:00AM the morning after my bivalent booster I woke up with itching on the top of my hand. I scratched it and it didn't help. I had clotrimazole and betamethasone. The next day I didn't feel it much. I called the nurse line and they advised to soak it in baking soda water and then BENADRYL cream. I got some relief before bed. The next day it began to become swollen, so I made an appointment with dermatologist. I called the nurse line again and let them know it was swollen. I took a BENADRYL allergy pill and slept well. The next day the swelling had covered the entire back of my hand. Originally it was only on the right side of my hand. The dermatologist told me he has seen reactions like this after the vaccines. Steroids do not help much. He gave me a sample of CERAVE. I used it a few times. By the weekend I was feeling better and as of today there is no evidence at all.
Pt states that for 12 hours after her flu shot she had a racing heartbeat. She said it was pretty scary. She did not go in for any medical treatment.
Patient received moderna vaccine on 3/16/21 and 4/13/21. COVID positive on 2/9/22 in ER, however patient states that it has been greater than 7 days since patient was a positive COVID test.. Presented to ER on 2/9/22 with left shoulder pain. Received levofloxacin and vancomycin for PNA.
had an average resting heartbeat of 90 beats per minute; was wheelchair bound for four months; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEART RATE ABNORMAL (non-serious), outcome "unknown", described as "had an average resting heartbeat of 90 beats per minute"; WHEELCHAIR USER (non-serious), outcome "unknown", described as "was wheelchair bound for four months". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was not clear in whether the AE was from the Moderna or Pfizer vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Large lump in arm pit, rash and itching in left arm around injection site and down into wrist.
A non-serious spontaneous report of pneumonia, sleeping a lot, fever, asthma and coughing was received from a mother concerning a six year-old female subsequent to FLUMIST. Medical history included asthma. No concomitant medications were reported for this patient. The patient received FLUMIST in the last week of August 2008. The patient developed a high fever (104 degrees Fahrenheit) 12 hours after receiving FLUMIST. The patient was taken to the emergency room and treated for pneumonia and an asthma attack. The patient was not hospitalized. Subsequently in September 2008, the patient had symptoms of coughing and sleeping a lot. The outcome of the adverse events was not reported. Additional dosing with FLUMIST was not reported. No causality assessment was reported.
He received Covid vaccines on 1/30/21, 2/27/21, and 11/15/21. On 5/25/22, he was brought to ER due to weakness, SOB, and runny nose. He was recently involved MVC and was released from the other hospital. He tested positive COVID requiring oxygen therapy, so he was admitted to the hospital. He received Remdesivir and Steroid. On 5/28/22, he complained of chest pain. Echo shoed cardiomyopathy with EF 35-40%. He went to ventricular fibrillation. He was coded twice. He was able to achieve return of spontaneous circulation but was still hypotensive with maximum support. His family decided DNR and pronounced death at 13:51 on 5/28.
On 1/8/2021 (eight days post-vaccination), a raised, red, and itchy region appeared around the injection site approximately the size of a quarter. On 1/9/2021, the reaction around the injection site stayed the same and the 2 lymph nodes distal to the injection site became swollen and red as well. On 1/10/2021, both reactions substantially subsided and are absent on 1/11/2021.
Symptoms started at midnight 12/16/20 and ended approximately 5:00pm 12/16/20, body aches, extreme fatigue , sore throat, sinus congestion, headache , pain and redness at injection site.
passed away; This is a spontaneous report from non-contactable consumers received via a Pfizer-sponsored program An 88-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL0142) via an unspecified route of administration on 30Dec2020 at a single dose (1 dose) in the left arm (LA) (administered by: senior living) as Covid vaccine. Medical history included patient was 14 plus days post COVID and unresponsive. The patient had no listed allergies. Concomitant medications were not reported. The patient passed away with an hour and half of receiving vaccine on 30Dec2020. Per nursing staff, they did not expect the patient to make it many more days. She was unresponsive in the room when shot was given. It was unknown if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: passed away
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On 26-JAN-2016, the patient received a dose of improperly stored GARDASIL injection (lot # K010215 with expiration date 05-MAY-2017; dose and route were not provided). No adverse effects were reported. The vaccination was exposed to temperature of 50.3F for 1 hour and 20 minutes. There was a previous temperature excursion of 48.9F for 2 hours. This is one of several reports received from the same reporter. Additional information has been requested.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Allergy.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. In March 2021, HEADACHE (headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 04-NOV-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L030587, expiry date: 10-FEB-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
a few hours after shot, arm startd to swell, warm to touch, tender. continues to spread downwards toward elbow
This spontaneous report was received from a physician refers to a female patient of unknown age. No medical history was reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot #, dose, route not reported) at an unspecified pharmacy and the patient questioned the storage of the ZSOTAVAX at the time she received the vaccine. No concomitant medications were reported. The patient stated she did not feel that the storage of the vaccine was "adequate". No known temperature conditions can be verified as the patient just felt it was not stored properly. Additional information is not expected.
Information has been received from a nurse referring to a patient of unknown age and gender. Concurrent condition and medical history were not reported. On 20-JAN-2016 the patient was vaccinated with improperly stored M-M-R II (lot # L015279, expiration date 30-APR-2017, dose and route were unknown). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
My heart was racing like crazy; I couldn't speak.; my arms and hands were numb; I was also extremely dizzy; This is a spontaneous report from a contactable Consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 28Oct2021 14:00 (Lot Number: FF2593) at the age of 40 years old as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included known allergies: Penicillin/Shellfish. No Covid prior vaccination. No other vaccine in four weeks. There were no concomitant medications.  On Sunday 31Oct2021 16:00, the patient ended up in the hospital. His heart was racing like crazy, his arms and hands were numb, he couldn't speak. He was also extremely dizzy. AE resulted in Emergency room/department or urgent care. It was unknown if treatment received. The outcome was unknown.   Follow-up attempts are completed. No further information is expected.